Boehringer Ingelheim and Salipro enter drug discovery partnership
The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Santé log23h
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
The Pharma Letter9h
EMA annual report 2024
At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
The Pharma Letter9h
Positive Phase III trial results for ensitrelvir
Japan’s Shionogi (TYO: 4507) yesterday delivered a late-breaking scientific oral presentation at the Conference of ...